Uncontrolled Hypertension and Non-adherence to Medical Therapy in Ulaanbaatar, Mongolia

Objectives: The purposes of this study were (1) to measure non-adherence to medical therapy in a representative sample of the hypertensive population in Mongolia; (2) to identify factors influencing non-adherence to anti-hypertensive medication; and (3) to compare non-adherence to medication in the uncontrolled and controlled hypertension groups. Methods: This descriptive study was a questionnaire-based cross-sectional analysis. A random sample of 735 hypertensive patients, aged 35-64 years was selected. Arterial hypertension was defined as uncontrolled if blood pressure ≥140/90 mmHg. Non-adherence to medication was assessed using the Morisky Medication Adherence Scale with a four-item questionnaire. Results: The study sample consisted of 265 men (36.1%) and 470 women (63.9%). The mean age of participants was 53.8 ± 8.7 years. Uncontrolled hypertension was detected in 84.7% of all hypertensive subjects. We wound 68.3% of hypertensive patient’s non-adherence to medical treatment. Significant factors influencing non-adherence to anti[1]hypertensive medication among the hypertensive population in Mongolia were younger age (35-44), low family income, not having a regular doctor for hypertension control, behavior of irregular medication intake and mono-therapy. Conclusion: Non-adherence to medical treatment was significantly more common in the uncontrolled hypertension group compared with controlled the hypertension group (79.3% vs. 7.1%, p<0.001)

The Burdens of Non-Communicable Disease, Cancer and Cardio-Oncology in Mongolia.

No abstract  in Englis

The Efficacy and Safety of “Kyushin” in Mongolian Patients with Ischemic Heart Disease and Heart Failure

Objectives: This study aimed to investigate the efficacy and safety of Kyushin in addition to conventional drug therapy. Methods: This study included 109 (Male/Female = 44/65) subjects were assigned to two groups (Kyushin and conventional treatment vs. conventional treatment alone) based on age, gender, and initial physiologic test values. Subjects in the Kyushin group received Kyushin 30 mg orally three times daily for eight weeks. Subjective complaints, physiological examinations (ECG, echocardiography, blood pressure, pulse rate) and laboratory tests were conducted at the start of the study and after eight weeks of treatment. The pre- and post-treatment Kyushin results were compared with the conventional treatment group’s findings. Results: In the patients treated with Kyushin, significant improvements were observed in these subjective complaints, physiological examinations (ECG, echocardiography, blood pressure, pulse rate) and laboratory tests. No adverse effects were observed during this study. Conclusions: This study shows that Kyushin is not only safe, it is more effective than conventional treatment alone in patients with ischemic heart disease and heart failure

The Screening, Awareness, Treatment, and Control of Dyslipidemia Among Adults in Ulaanbaatar, Mongolia

Objective: The prevalence of dyslipidemia continues to increase in recent decades in Mongolia; however, little is known about awareness, treatment, and control of dyslipidemia. The aim of this study was to assess the awareness, treatment, and control of dyslipidemia in adults in Ulaanbaatar, Mongolia. Methods: This cross-sectional study was conducted between June 2017 and March 2018. A total of 326 people in Ulaanbaatar participated in this study. Results: Out of the 326 participants, 224 (68.7%, 64.9 in females; 75% in males) had dyslipidemia, and around the one third 113 (34,7%) were aware of the condition. Out of the 224 dyslipidemia individuals, only 27 (8.3%) were on statin treatment. Among those individuals receiving treatment, 19 (70.4%) serum lipid level was under the desired level. Conclusion: Our study revealed an alarmingly high prevalence of dyslipidemia, low level of awareness, insufficient treatment, yet a comparatively high level of control of dyslipidemia among the adults aged 20- 69 in Ulaanbaatar relative to some other countries. The awareness, treatment, and control of dyslipidemia in the rural parts of Mongolia are unknown

Agreement regarding overcoming hypertension in the Asian Hypertension Society Network 2022

The global burden of hypertension has already been acknowledged. The reduction in blood pressure (BP) significantly reduces cardiovascular morbidity and mortality. Half of the world’s population is concentrated in Asia, and this proportion is expected to continue to increase. As the population ages, the number of people suffering from hypertension is also expected to increase. It is critical to address hypertension in Asia. To do so, it is necessary to establish a common direction for the control of hypertension within the Asian region. Within Asia, religions and cultures differ, and economic development differs from region to region. However, despite this diversity, things will not progress efficiently or in a certain direction unless certain rules are in place. After convening the International Society of Hypertension (ISH) 2022 in Kyoto, Japan, we would like to present the direction agreed upon by the regional hypertension societies toward the goal of addressing hypertension in Asia. In particular, we focused on three points: target BP, sodium restriction, and out-of-office BP measurement

2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action

This fact sheet and global call to action is aimed at nutrition, hypertension, cardiovascular and other health care clinicians and scientists, and health advocates, as well as the organizations to which they belong. The ‘call’ is to align these audiences with the facts on: the burden of disease and key evidence supporting reductions in dietary sodium, the consistent recommendations for reducing dietary sodium from unbiased and comprehensive health and scientific reviews, the current levels of sodium intake, the cost savings expected from reducing high dietary sodium, the sources of controversial opinions, the current recommended approaches to reduce dietary sodium, and how to stay up to date with evidence on how to reduce dietary sodium and the evolving research on the adverse health effects of a high sodium intake. Health, nutrition, hypertension and cardiovascular organizations, and their members, need to become more engaged and advocate for reductions in dietary sodium, and for a greater priority to be given to high quality research on dietary sodium. The World Hypertension League, Resolve to Save Lives and International Society of Hypertension are committed to support reductions in dietary sodium as a high priority